Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing

CONCLUSION: A SBRT dose-escalation to 5 × 9 Gy on the prostate while sparing the urethra + 2 mm at 36.25 Gy is feasible without compromising dose coverage to the tumor. This radiation regimen will be used for a Phase-III trial.ADVANCES IN KNOWLEDGE: In prostate SBRT, dose optimization on the urethra is feasible and could decrease urinary toxicities.PMID:34283647 | DOI:10.1259/bjr.20210142

Source: The British Journal of Radiology - July 20, 2021 Category: Radiology Authors: Salim Benhmida Amandine Beneux Corina Udrescu Olivier Rouviere Samy Horn Ciprian Enachescu Ariane Lapierre Olivier Chapet Source Type: research